{"id":"W2167573905","doi":"10.1016/j.clinthera.2005.09.007","title":"Incidence of infection during efalizumab therapy for psoriasis: Analysis of the clinical trial experience","year":2005,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":false,"ca_institutions":"Royal Victoria Hospital; Dalhousie University","funders":"Genentech","keywords":"Efalizumab; Medicine; Psoriasis; Placebo; Incidence (geometry); Clinical trial; Adverse effect; Internal medicine; Randomized controlled trial; Immunology; Plaque psoriasis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001859318,0.0004817475,0.003837855,0.000236994,0.0001700317,0.0000112154,0.0007491653,0.001630667,0.0001131442],"category_scores_gemma":[0.0005031048,0.0002927904,0.005903472,0.0009788304,0.0007547628,0.00005515823,0.0001363981,0.0005675515,0.00001250603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005592019,"about_ca_system_score_gemma":0.0003675346,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001524697,"about_ca_topic_score_gemma":0.00002687666,"domain_scores_codex":[0.9928825,0.002319195,0.003660258,0.0006824627,0.0001101056,0.0003454313],"domain_scores_gemma":[0.9914563,0.004393872,0.002687084,0.001225044,0.0002035302,0.00003412979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005696024,0.001049044,0.00254804,0.0002730098,0.01473107,2.963646e-7,0.0001206935,0.000002109661,0.000007891334,0.00004567379,0.00001464965,0.9755115],"study_design_scores_gemma":[0.02622962,0.001633526,0.008196642,0.001060957,0.03326081,0.000005750141,0.00002197722,0.000004800078,0.0001860945,0.00003600958,0.9289055,0.0004582998],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1157493,0.8778932,0.00005954537,0.00001248321,0.004201337,0.001857951,0.0001693694,0.00003134467,0.00002543311],"genre_scores_gemma":[0.0126464,0.9859699,0.00009180696,0.00005647859,0.0005038735,0.0002949916,0.000100558,0.00004216939,0.0002937982],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9750532,"threshold_uncertainty_score":0.9999524,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.27534577022948,"score_gpt":0.4846407011721711,"score_spread":0.2092949309426911,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}